Back to ZLTQ
ZELTIQ(R) Aesthetics Promotes Joshua T. Brumm to Senior Vice President

PLEASANTON, Calif., May 8, 2012 (GLOBE NEWSWIRE) -- ZELTIQ Aesthetics, Inc. (Nasdaq:ZLTQ) a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that the Board of Directors has promoted Chief Financial Officer Joshua Brumm to Senior Vice President, from Vice President. Mr. Brumm has served as Vice President and Chief Financial Officer since January 2012. Prior to that, he served as Vice President, Corporate Development and Investor Relations. Mr. Brumm will continue to oversee all financial operations, corporate development, information technology and investor relations functions.

Mark Foley, interim President and Chief Executive Officer, said, "Since Josh stepped into the CFO role in January, he has made a number of significant contributions that have strengthened the finance team and operational management of ZELTIQ. We have complete confidence that he will continue to be an invaluable member of the executive team. We look forward to his continued leadership in this role."

About ZELTIQ Aesthetics

ZELTIQ®  Aesthetics is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. The Company's first commercial product, the CoolSculpting System, is designed to selectively reduce stubborn fat bulges that may not respond to diet or exercise. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. CoolSculpting utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis, without causing scar tissue or damage to the skin, nerves, or surrounding tissues. ZELTIQ developed CoolSculpting to safely, noticeably, and measurably reduce the fat layer within a treated fat bulge without requiring the patient to diet or exercise.

CONTACT: Josh Brumm
         ZELTIQ Aesthetics, Inc.
         SVP, and Chief Financial Officer
         Nick Laudico / Amy Glynn
         The Ruth Group
         646-536-7030 / 7023
Back to ZLTQ
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki